Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007;68 Suppl 1(Suppl 1):S12-6.
doi: 10.1016/j.surneu.2007.07.079.

Intravenous rt-PA: a tenth anniversary reflection

James Grotta  1 , John Marler
Affiliations
Review

Intravenous rt-PA: a tenth anniversary reflection

James Grotta et al. Surg Neurol. 2007.

Abstract

Background: Clinical trials with rt-PA for treating AIS began 20 years ago in 1987, and the pivotal NINDS rt-PA Stroke Study was completed and published in 1995 with FDA approval in 1996, about 10 years ago. A large number of articles emanated from that study and have established the efficacy and generalizability of this treatment.

Methods: Here we summarize the background of how the NINDS trial was developed and carried out and its main findings.

Results: The NINDS rt-PA Stroke Study resulted from preclincal and pilot studies and paralleled similar studies carried out around the world. Its positive results, compared with the other trials, probably were due to the early time window for treatment and well-organized clinical and statistical centers. Many controversies have surrounded its use since its approval. As a result of the NINDS rt-PA Stroke Study, many new approaches to thrombolytic therapy are under evaluation.

Conclusion: The results of the NINDS rt-PA Stroke Study have affected the management of patients with acute stroke worldwide.

PubMed Disclaimer

References

    1. Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke. Circulation. 1996;94:1167–1174. - PubMed
    1. Adams HP, Jr, Kenton EJ, 3rd, Scheiber SC, Juul D. Vascular neurology: a new neurologic subspecialty. Neurology. 2004;14;63(5):774–776. - PubMed
    1. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA. 2000;283:1145–1150. - PubMed
    1. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, Starke RD, Todd HW, Viste KM, Girgus M, Shephard T, Emr M, Shwayder P, Walker MD. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 2000;283(23):3102–9. - PubMed
    1. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabine J, Montaner J, Saqqur M. Demchuk AM, Moye LA, Hill MD, Wojner AW, CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170–8. - PubMed

MeSH terms

Substances